Exploration of the Molecular Mechanism of FUZI (Aconiti Lateralis Radix Praeparata) in Allergic Rhinitis Treatment Based on Network Pharmacology

• Published in: Medical science monitor Vol. 26; p. e920872
• Main Authors: Chen, Xiangjing, Wang, Renzhong, Meng, Wei, Zhang, Xin
• Format: Journal Article
• Language: English
• Published: United States International Scientific Literature, Inc 01-03-2020
• Subjects: Aconitum; Anti-Inflammatory Agents - pharmacology; Drug Information Services; Drugs, Chinese Herbal - pharmacology; Humans; Immunity - drug effects; Medicine, Chinese Traditional - methods; Plant Extracts - pharmacology; Review; Rhinitis, Allergic - drug therapy; Rhinitis, Allergic - immunology
• ISSN: 1643-3750; 1234-1010; 1643-3750
• DOI: 10.12659/MSM.920872

FUZI (Aconiti Lateralis Radix Praeparata) is a traditional Chinese medicine herb used extensively for nourishing yang (regarded as the positive, male universal force), which is critical in treatment of allergic rhinitis. In this paper, FUZI was explored based on network pharmacology. The active components of FUZI were screened out, its protein targets were assessed, and the protein interaction network map was built with the differential protein of allergic rhinitis, as an attempt to determine the critical targets of FUZI for treating allergic rhinitis. Subsequently, DAVID was employed to explore the biological function and pathway enrichment to determine the biological pathway of FUZI for treating allergic rhinitis. As suggested by the results, FUZI is likely to affect the inhibition of inflammation and the regulation of immunity, probably reducing the incidence of allergic rhinitis, or alleviating nasal discomfort attributed to allergic inflammation. The targets and pathways of FUZI for treating allergic rhinitis assessed by network pharmacology provided a direction for our subsequent studies and may be a novel therapeutic target.